Teleflex and Arrow International Recall ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits for Increased Resistance That May Lead to Vessel Injuries, Narrowing, or Blockage

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product  Product Name: ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits Product Codes: See Recall Database Entry  Devices Recalled in the U.S.: 334,995  Dates Distributed: December…

AvKARE, LLC. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750 mg/5 mL Due to Potential Bacillus Cereus Contamination

Summary Company Announcement Date: April 01, 2024 FDA Publish Date: April 01, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Potential Bacillus cereus contamination Company Name: AvKARE, LLC Brand Name: Brand Name(s) Product Description: Product Description Atovaquone Oral Suspension, USP 750mg/5mL Company Announcement FOR IMMEDIATE RELEASE – 3/29/2024 –AvKARE, LLC. is voluntarily recalling…

Amneal Pharmaceuticals, LLC. Issues a Nationwide Voluntary Recall of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5mL, Due to the Potential for Some Bottles to be Super Potent Which May be Harmful

Summary Company Announcement Date: March 27, 2024 FDA Publish Date: March 27, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Super potent due to bottles being overfilled Company Name: Amneal Pharmaceuticals, LLC. Brand Name: Brand Name(s) Product Description: Product Description Vancomycin Hydrochloride for Oral Solution, USP, 250 mg/5mL Company Announcement FOR IMMEDIATE RELEASE…

Eugia US LLC (f/k/a AuroMedics Pharma LLC) Issues Voluntary Nationwide Recall of Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single Dose Vial) Due to Presence of White Particles

Summary Company Announcement Date: March 28, 2024 FDA Publish Date: March 28, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Device & Drug Safety – Presence of Particulate Matter Company Name: Eugia US LLC Brand Name: Brand Name(s) Eugia US LLC Product Description: Product Description Methocarbamol Injection, USP 1000 mg/10 mL (100mg/mL) (Single…

Voluntary Removal Announcement for the InfuTronix Nimbus Ambulatory Infusion Pump System

Summary Company Announcement Date: March 20, 2024 FDA Publish Date: March 20, 2024 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Recall due to a high number (3698) of customer complaints related to the Nimbus Infusion Pump systems Company Name: InfuTronix, LLC Brand Name: Brand Name(s) Product Description: Product Description Nimbus Pump System…

Pyramid Wholesale Issues Recall of Various Brands of Products Sold as Dietary Supplements for Sexual Enhancement Because They Contain Undeclared Prescription Drugs Including Sildenafil (Viagra) and/or Tadalafil (Cialis)

Summary Company Announcement Date: March 19, 2024 FDA Publish Date: March 20, 2024 Product Type: Dietary SupplementsDrugs Reason for Announcement: Recall Reason Description Undeclared Sildenafil and/or Tadalafil Company Name: Pyramid Wholesale Brand Name: Brand Name(s) Product Description: Product Description Dietary supplements for sexual enhancement Company Announcement FOR IMMEDIATE RELEASE – March 19, 2024, Los Angeles,…